| Date Filed | Type | Description |
| 10/05/2023 |
4
| Brainard Diana (CEO) has filed a Form 4 on Allovir, Inc.|
Txns:
| Sold 1,325 shares
@ $1.9763, valued at
$2.6k
|
|
| 10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
4
| Brainard Diana (CEO) has filed a Form 4 on Allovir, Inc.|
Txns:
| Sold 11,361 shares
@ $2.4955, valued at
$28.4k
Sold 4,055 shares
@ $2.7898, valued at
$11.3k
|
|
| 08/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/06/2023 |
4
| Brainard Diana (CEO) has filed a Form 4 on Allovir, Inc.|
Txns:
| Sold 5,275 shares
@ $3.0451, valued at
$16.1k
|
|
| 07/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/19/2023 |
4
| Brainard Diana (CEO) has filed a Form 4 on Allovir, Inc.|
Txns:
| Sold 4,536 shares
@ $4.214, valued at
$19.1k
|
|
| 05/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/23/2023 |
4
| Brainard Diana (CEO) has filed a Form 4 on Allovir, Inc.|
Txns:
| Sold 5,122 shares
@ $6.6254, valued at
$33.9k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2023 |
4
| Brainard Diana (CEO) has filed a Form 4 on Allovir, Inc.|
Txns:
| Sold 34,435 shares
@ $5.0777, valued at
$174.9k
|
|
| 11/21/2022 |
4
| Brainard Diana (CEO) has filed a Form 4 on Allovir, Inc.|
Txns:
| Sold 4,515 shares
@ $7.2669, valued at
$32.8k
|
|
| 09/20/2022 |
4
| Brainard Diana (Director) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 10,200 shares
@ $0
Granted 20,400 options
@ $3.47, valued at
$70.8k
|
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Brainard Diana (CEO) has filed a Form 4 on Allovir, Inc.|
Txns:
| Granted 315,000 shares
@ $0
Granted 585,000 options to buy
@ $9.15, valued at
$5.4M
|
|
| 11/15/2021 |
4
| Brainard Diana (Director) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 18,360 shares
@ $0
Granted 36,720 options
@ $13.55, valued at
$497.6k
|
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2020 |
4
| Brainard Diana (Director) has filed a Form 4 on Allovir, Inc.|
Txns:
| Bought 6,300 shares
@ $17, valued at
$107.1k
|
|
| 07/31/2020 |
4
| Brainard Diana (Director) has filed a Form 4 on Allovir, Inc.|
Txns:
| Granted 45,000 options to buy
@ $17, valued at
$765k
|
|
| 07/29/2020 |
3
| Brainard Diana (Director) has filed a Form 3 on Allovir, Inc. |